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Background: COPD is a highly prevalent disease but underdiagnosed, undertreated and possibly
under-recognized by patients. Limited information exists regarding patients’ perception of
COPD severity. We compared patients’ general health status perception, degree of breathless-
ness and physical activity limitation with the severity of their respiratory condition measured
by airway obstruction, in a population-based sample.
Methods: We used postbronchodilator FEV1/FVC< 0.70 to define COPD. Patients’ perception
of their general health status was derived from the question ‘‘in general you would say that
your health is: excellent, very good, good, fair or poor?’’
Results: Spirometry was performed in 5314 subjects: an FEV1/FVC ratio below 0.70 was found
in 759 subjects. In persons with COPD, general health status decreased with increasing GOLD2 605 3382; þ58212 605 3395; fax: þ58212 2398982.
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General health status perception in COPD 1377stages. Over one-half of subjects with stage 2 and one third of those with stages 3 and 4 re-
ported their health status as good to excellent. There was also a disparity between airway
obstruction severity and breathlessness intensity. Although the more severe COPD stages were
frequently associated with significant compromise of work and everyday activities, patients
often tended to provide an optimistic self evaluation of their health status.
Conclusions: The discrepancy observed between general health status, dyspnea severity,
physical activity limitation and airway obstruction most likely reflect patients’ underpercep-
tion of disease severity, emphasizing the need for improving case-finding measures and
multi-component evaluation of COPD subjects.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is a highly
prevalent disease worldwide and different studies have
shown that is often underdiagnosed and undertreated by
physicians, and possibly under-recognized by patients.1e14
PLATINO was a population-based epidemiologic study
designed to evaluate the prevalence of COPD in five Latin
American cities (Sa˜o Paulo, Santiago de Chile, Mexico City,
Montevideo, and Caracas). PLATINO reported crude rates of
COPD (GOLD stage 1 or higher) between 7.8% and 19.7%.1
Other reports from this study indicated that COPD is often
underdiagnosed, misdiagnosed and undertreated not only
in its early stages, but even when lung function is severely
impaired.6,12
In selected COPD samples several studies have shown
that health status correlates to a moderate degree with
assessment of dyspnea and with FEV1, the most often used
clinical indicator of severity in COPD.15,16 Taken together,
these findings suggest that health status probably expresses
the respiratory as well as the systemic consequences of this
complex disease.
Although the diagnosis of COPD is commonly based on
the presence of characteristic symptoms, patients with
COPD frequently appear to poorly recognize and perceive
their symptoms and disease severity.14 There is also an
apparent discrepancy between patients’ own assessment
of disease severity and the intensity of breathlessness,
activity limitation and airway obstruction. In a telephone
survey of persons diagnosed with COPD, Rennard et al.
found that many subjects underestimate the severity of
their disease, indicating a discrepancy between the
patient’s perception of their health status and the doc-
tor’s perception of the impact of COPD in the patient.14
Why do COPD patients with severe COPD judge their
disease as mild to moderate? Limited information exists
in this area (patients’ perception of disease severity)
from an unselected COPD population.17 The PLATINO
study offers a good opportunity to assess different
aspects of the disease such as general health status in
a large population-based sample from five Latin American
cities with high (80%) participation and robust, well-
established methods.1 The aim of the present study was
to assess patients’ perceptions of their general health
status and the severity of their respiratory condition, as
measured by the degree of breathlessness, physical
activity limitation, and airway obstruction, in the PLAT-
INO COPD population.Methods and materials
Complete details of the PLATINO methodology and detailed
descriptions of participation rates have been published
elsewhere.1,6,12,18,19 Briefly, a two-stage cluster sampling
method was used at each site in order to obtain a proba-
bility sample of households. All adults aged 40 or older
living in the selected households were invited to partici-
pate. Approval was obtained from the ethical committee of
the institutions involved in the study and written informed
consent was obtained from each subject.
Information was collected on several factors potentially
associated with COPD, including demographics, smoking
habits, years of formal education, employment, respiratory
symptoms, and prior spirometric testing. Copies of the
questionnaires are available at the PLATINO website
(http://www.platino-alat.org). A portable, battery oper-
ated, ultrasound transit-time based spirometer (Easy-
One; NDD Medical Technologies, Chelmsford MA and
Zu¨rich, Swizerland) was used to perform pulmonary func-
tion testing.
We used the definition and stratification of COPD
proposed by the Global Initiative for Chronic Obstructive
Lung Disease (GOLD): a ratio of the post-bronchodilator
FEV1 over FVC below 0.70.
20 Interviews were completed in
5571 subjects from a total of 6711 eligible individuals, and
spirometry was performed in 5314 subjects. Among this
population there were 759 subjects with post-
bronchodilator FEV1/FVC< 0.70 (COPD) and 4555 individ-
uals with a postbronchodilator FEV1/FVC 0.70.
Patients’ perception of their general health status was
derived from the question ‘‘in general you would say that
your health is: excellent, very good, good, fair or poor?’’
Information regarding physical activity limitation was
assessed using the SF-12 physical score.21
Severity of airway obstruction was assessed by the GOLD
stages and the perceived severity of the degree of
breathlessness using the following dyspnea scale22:
Grade 1. No report of dyspnea
Grade 2. Walks slower than people of the same age on
the level because of dyspnea.
Grade 3. Stops for breath when walking at own pace on
the level.
Grade 4. Stops for breath after walking about 100 m or
after a few minutes on the level.
Grade 5. Too breathless to leave the house or breathless
when dressing or undressing.
1378 M. Montes de Oca et al.A simple comorbidity score was calculated by counting
the number of comorbid conditions (any cardiovascular
disease, diabetes, peptic ulcer, and asthma) reported by
each subject.
Statistical analyses
Descriptive analyses were performed using Pearson’s Chi2
tests to compare groups for categorical variables and
Cuzick’s nonparametric test for trend and 2-sided t-tests
for continuous variables. The relationship between healthTable 1 Description of subjects with COPD by health status ca
Variables Excellent
(nZ 55)
Very good
(nZ 74)
n (%) n (%)
Age, years (mean SD) 63.2 11.7 65.0 12.2
Gender (Female) 25 (45.5) 34 (46.6)
BMI
Underweight 1 (1.8) 5 (6.8)
Normal 17 (30.9) 26 (35.1)
Overweight 26 (47.3) 28 (37.8)
Obese 11 (20.0) 15 (20.3)
Ethnicity (White) 37 (67.3) 53 (71.6)
Education, years (mean SD) 6.9 4.8 8.6 5.7
Employed (Yes) 24 (43.6) 40 (54.1)
Leisure impairment (Yes) 4 (7.3) 0 (0.0)
Smoking status
Never 9 (16.4) 20 (27)
Former 23 (41.8) 28 (37.8)
Current 23 (41.8) 26 (35.1)
Respiratory symptoms
Cough 11 (20.0) 17 (23.0)
Phlegm 13 (23.6) 17 (23.0)
Wheeze 15 (27.3) 11 (14.9)
Dyspnea 18 (33.3) 29 (39.2)
Any symptom 36 (65.5) 45 (60.8)
Comorbidity Score (mean SD) 0.91 0.97 0.74 0.79
FVC, liters (mean SD) 3.4 1.0 3.6 0.9
FEV1, liters (mean SD) 2.2 0.7 2.3 0.6
FEV1/FVC (mean SD) 64.1 5.3 63.6 6.6
SF-12 physical score (mean SD) 56.2 4.9 55.1 4.9
SF-12 mental score (mean SD) 55.3 7.7 53.8 8.4
Moderate activities
Limited a lot 3 (5.5) 3 (4.1)
Limited little 4 (7.3) 8 (10.8)
Not limited at all 48 (87.3) 63 (85.1)
Climbing stairs
Limited a lot 4 (7.3) 2 (2.7)
Limited little 3 (5.5) 12 (16.2)
Not limited at all 48 (87.3) 60 (81.1)
Limitation due to physical
health (Yes)
5 (9.1) 6 (8.1)
Work limitation due to
physical health (Yes)
4 (7.3) 1 (1.4)
BMIZ body mass index; FVCZ forced vital capacity; FEV1Z forced e
Comorbidity score includes self-reported heart disease, hypertensionstatus and COPD severity was examined using logistic
regression, adjusted for survey design and other variables.
All analyses were performed using the STATA statistical
software package (STATA versions 9.2 and 10.1; STATA
Corporation; College Station, TX).
Results
A description of the population with COPD by health status
categories is presented in Table 1. In subjects with COPD
about 7% described their health as excellent, 10% verytegories.
Good
(nZ 348)
Fair
(nZ 258)
Poor
(nZ 24)
p-value
n (%) n (%) n(%)
64.4 12.9 63.6 11.7 65.4 11.1 0.860
155 (44.5) 138 (53.5) 10 (41.7) 0.248
0.253
19 (5.5) 22 (8.5) 4 (16.7)
105 (30.2) 77 (29.8) 5 (20.8)
150 (43.1) 90 (37.9) 9 (37.5)
74 (21.3) 69 (26.7) 6 (25.0)
249 (71.6) 137 (53.1) 13 (54.2) <0.0001
7.0 4.4 5.8 4.2 4.9 5.9 <0.0001
204 (58.6) 157 (60.9) 17 (70.8) 0.105
26 (7.5) 36 (14.0) 15 (62.5) <0.0001
0.198
114 (32.8) 89 (34.5) 7 (29.2)
109 (31.3) 76 (29.5) 11 (45.8)
125 (35.9) 93 (36.1) 6 (25.0)
95 (27.3) 103 (39.9) 12 (50.0) <0.0001
76 (21.8) 98 (38.0) 11 (45.8) <0.0001
117 (33.6) 135 (52.3) 17 (70.8) <0.0001
149 (43.4) 162 (63.8) 21 (91.3) <0.0001
239 (68.7) 219 (84.9) 23 (95.8) <0.0001
1.03 0.97 1.44 1.15 2.17 1.09 <0.0001
3.5 1.1 3.2 1.1 2.9 1.1 0.001
2.2 0.7 2.0 0.8 1.8 0.8 <0.0001
62.6 7.6 60.4 9.8 58.9 10.8 0.001
50.9 7.6 44.5 8.9 31.2 6.2 <0.0001
52.7 9.1 47.4 11.8 38.3 13.4 <0.0001
<0.0001
22 (6.3) 38 (14.7) 12 (50.0)
45 (12.9) 55 (21.3) 8 (33.3)
281 (808) 165 (64.0) 4 (16.7)
<0.0001
33 (9.5) 57 (22.1) 14 (58.3)
71 (20.4) 77 (29.8) 7 (29.2)
244 (70.1) 124 (48.1) 3 (12.5)
59 (17.0) 96 (37.2) 21 (87.5) <0.0001
53 (15.2) 94 (36.4) 21 (87.5) <0.0001
xpiratory volume in one second.
, stroke, diabetes, gastritis/ulcer and asthma.
Figure 1 General health status in non obstructed subjects
and in COPD subjects by GOLD severity stages (nZ 759).
General health status perception in COPD 1379good, 46% good, 34% fair and 4% poor. As health status
decreased in COPD subjects there was a progressive
increase in leisure impairment, frequency of respiratory
symptoms (cough, phlegm, wheezing and dyspnea), and
comorbidity score, whereas the proportion of white
subjects, education level and mean FVC, FEV1 and FEV1/
FVC values decreased. The SF-12 physical and mental
scores progressively decreased as health status deterio-
rated. Among COPD subjects reporting fair to excellent
health status, over 64% indicated they had no difficulty with
average physical activity, compared with 17% in subjects
reporting poor health status. Difficulty with vigorous phys-
ical activity (e.g., climbing stairs) was reported in 3e22% of
COPD subjects with fair to excellent health status and in
58% in the poor category. Although the proportion of COPD
subjects with limitation in work or in daily activities due to
the physical health progressively increased as health status
decreased, almost two third of subjects reporting fair to
excellent health status reported no limitation.
The relation between self-reported health status
(goodeexcellent) and disease severity (GOLD 1 vs. GOLD
2e4) was assessed using a multivariate analysis (Table 2).
The significant variables were: SF-12 mental subscore
(higherZ better health status), prior diagnosis of COPD
(yesZworse health status), years of school (high-
erZ better health status), race (nonwhiteZworse health
status), comorbidity score (higher scoreZ lower health
status), and presence of any respiratory symptom (symp-
tomsZ lower health status). After including these vari-
ables in the model, COPD severity was not statistically
significant. The addition of age, gender, BMI, FEV1 change
after bronchodilator, and pack-years of smoking did not
alter the model significantly (data not shown).
General health status in non obstructed subjects and in
COPD subjects by GOLD severity stages is shown in Fig. 1.
The proportion of subjects in the different heath status
categories was quite similar in stage 1 COPD and subjects
without obstruction. In persons with COPD, the general
health status decreased with increasing GOLD stages.
However over one half (58.6%) of COPD subjects with stageTable 2 Multivariate regression model examining factors
associated with good to excellent health status among
subjects with COPD (nZ 757).
OR 95% Confidence
interval
SE p
GOLD stage 2e4 0.79 0.56 1.10 0.22 0.166
SF-12 mental subscore 1.05 1.04 1.07 0.01 <0.001
Prior COPD diagnosis 0.33 0.19 0.57 0.09 <0.001
Years of school 1.08 1.04 1.13 0.03 <0.001
Race (Nonwhite) 0.44 0.31 0.62 0.08 <0.001
Comorbidity score 0.73 0.61 0.87 0.07 <0.001
Any respiratory
symptom
0.52 0.35 0.79 0.11 0.002
Leisure impairment
(Yes)
0.65 0.38 1.11 0.18 0.117
The entire table represents a single multivariate regression
model.2 and one-third of subjects with stages 3 and 4 disease
reported their health status as good to excellent.
Dyspnea grade in non obstructed subjects and in COPD
subjects by GOLD severity stages are shown in Fig. 2. Eleven
subjects with COPD (GOLD stage 1Z 5; GOLD stage 2Z 6)
were missing data on dyspnea grade. Stage 1 COPD subjects
and non obstructed subjects had a similar distribution of
dyspnea grade. Over 90% of COPD subjects with stage 2 and
all those with stages 3 and 4 reported dyspnea of grade 2 or
lower.
Physical activity limitation in non obstructed subjects
and in COPD subjects by GOLD severity stages is shown in
Table 3. The physical score and the reported limitation in
work or in daily activities were quite similar between stage
1 COPD subjects and non obstructed subjects. In persons
with COPD the physical score progressively decreased with
increasing GOLD stages. Slightly over one-quarter of COPD
subjects with stage 2 reported limitation in work or in daily
activities versus approximately half of those with more
severe stages.
Discussion
In persons with COPD, general health status decreased with
increasing GOLD stages. However, over one-half of COPD
subjects with stage 2 and one third of those with stages 3
and 4 reported their health status as good to excellent. In
addition more than half of the COPD subjects with dyspnea
severity of 2 and 3 reported good to excellent health.
Although the more severe COPD stages were frequentlyFigure 2 Dyspnea grade in non obstructed subjects and in
COPD subjects by GOLD severity stages (nZ 748).
Table 3 Relationship between physical limitation and GOLD severity stages in persons with obstruction.
Variables No Obstruction
(nZ 4,549)
Stage 1
(nZ 451)
Stage 2
(nZ 256)
Stage 3&4
(nZ 52)
P
n (%) n (%) n (%) n (%)
SF-12 physical score (mean SD) 50.9 8.1 50.0 8.4 48.7 9.2 40.1 11.2 <0.0001
Moderate activities <0.0001
Limited a lot 232 (5.1) 36 (8.0) 24 (9.4) 18 (34.6)
Limited little 610 (13.4) 58 (12.9) 48 (18.8) 14 (26.9)
Not limited at all 3,712 (81.5) 357 (79.2) 184 (71.9) 20 (38.5)
Climbing stairs <0.0001
Limited a lot 343 (7.5) 44 (9.8) 42 (16.4) 24 (46.2)
Limited little 888 (19.5) 98 (21.7) 60 (23.4) 12 (23.1)
Not limited at all 3,322 (73.0) 309 (68.5) 154 (60.2) 16 (30.8)
Limitation due to physical
health (Yes)
817 (17.9) 89 (19.7) 69 (27.1) 29 (55.8) <0.0001
Work limitation due to
physical health (Yes)
780 (17.1) 80 (17.7) 67 (26.2) 26 (50.0) <0.0001
1380 M. Montes de Oca et al.associated with significant compromise of work and
everyday activities, these subjects tended to rank their
general health status from fair to excellent.
Previously we have reported a high prevalence of undi-
agnosed COPD (12.7%) in Latin America.6 The National
Health and Nutrition Examination Survey showed that
undiagnosed airflow obstruction in the general population
was frequently associated with impaired health and func-
tional status.23 In the current study, prior diagnosis of COPD
among persons with obstruction was significantly associated
with worse general health status (Table 2). Thus, it seems
likely that COPD subjects with worse general health are
more likely to come to diagnosis, probably due to more
frequent encounters with a physician.
The natural progression of COPD results in functional
impairment and limitations in activities of daily living. As
a consequence, patients enter a vicious cycle of inactivity
that leads to physical deconditioning. This is associated
with development of dyspnea at lower exercise intensities
and significant deterioration of health status. Depression
and anxiety may further reinforce the social isolation and
physical inactivity of these patients. Factors such as the
limitations in daily living activities, the need to change jobs
or consider earlier retirement, and the restriction of
recreational interests result in progressive depression, and
these changes in lifestyle impair quality of life. Although
the sequence and relationship among these mechanisms
seem to be logical, several studies have shown that global
health status in COPD correlate weakly with physiologic
variables such as FVC, FEV1, and diffusing capacity, and
moderately with exercise capacity, dyspnea severity,
anxiety, and depression.15,16,24,25
There is increasing evidence documenting a disparity
between the patient’s perception of disease severity, the
impact of COPD symptoms (particularly dyspnea) and the
physician’s clinical evaluation of COPD severity. Several
reports indicate that the patient’s perception of COPD
symptom burden frequently does not correspond with the
degree of airflow limitation.26e28 Although the severity of
COPD is most commonly assessed using a single physiolog-
ical measurement e the FEV1 e it is well known that FEV1does not correlate well with dyspnea and health-related
quality of life.17,26e29 Along this line, the results of the
present study show that over 90% of the COPD subjects with
stage 2 and higher reported the mildest level of breath-
lessness. This finding might be due, at least in part, to
limitations in the MRC as an instrument to measure dyspnea
severity. For example, ‘‘the mildest level of breathless-
ness’’ in the MRC scale is not really very mild (walking
slower than people of the same age on the level). The
results therefore argue in favor of using a multi-component
approach to stratify COPD severity, such as the BODE index
which, in addition to the degree of airway impairment,
incorporates the perceptive and the systemic components
of the disease.30
There is also an apparent discrepancy between the
measure of dyspnea severity and the patient’s perception
of health status. Results from the Confronting COPD Inter-
national Survey indicate that subjects with COPD appear to
underestimate their morbidity.14 There was a significant
disparity between subject’s perception of disease severity
and their degree of breathlessness. The overall impression
is that subjects with COPD appear to underestimate their
morbidity and may consequently be diagnosed on late
form. That study had an important limitation as a conse-
quence of its design, namely the lack of lung function data,
therefore determination of COPD diagnosis was based on
subjects’ report of a prior diagnosis, which is subject to
recall bias.
The results of our study show, that despite general
health status deterioration with airway obstruction
progression, an important proportion of severely obstruc-
ted COPD reported good to excellent health status. We also
found discrepancies between the limitation in the work or
in daily activities and the patient’s own assessment of their
general health status. These findings are consistent with
those reported by Rennard et al.14 and suggest that COPD
subjects are generally optimistic about their general health
status, are probably adapted to their chronic limitation,
have adjusted their health status baseline, and may have
an attitude of denial or negligence caused by a certain
lifestyle (smoking), thus failing to perceive the severity of
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General health status perception in COPD 1381their obstructive disease. It would be interesting to know if
the patients think that COPD is less important than
cardiovascular or malignant diseases, problems that have
received much more attention in the mass media than
COPD.
In selected COPD patients a perception of poor health
has been positively associated with symptoms of anxiety,
depression, and sleep disturbances.24,25 Although the
analysis of these factors was not included in the present
study, they could be assessed in an epidemiologic sample.
Therefore, future studies are necessary to evaluate their
influence and to better understand the factors determining
general health status in COPD.
These results reinforce the idea that screening or case-
finding of subjects at risk for COPD could be justified by the
frequent presence of cases suffering a significant but
underestimated disease, if we had stronger evidence of
screening cost-effectiveness, or interventions demon-
strated to alter the natural course of disease such as
smoking cessation.
Because of the characteristics of the PLATINO study, our
definition of COPD was based on post-bronchodilator FEV1/
FVC< 0.70 at a single examination. Although the use of the
fixed 0.70 cutoff rather than lower limit of normal to
diagnose airflow obstruction may overestimate the preva-
lence of the disease in the elderly and does not represent
a definitive clinical diagnosis, for practical reasons it is the
most widely accepted definition of diagnosing COPD in
current guidelines, and represents a simplified case defi-
nition for epidemiological purposes. The analysis and
comparison of COPD perception using other definitions
could be an interesting aim for future research.
In summary, this study indicates that, although in
persons with COPD, the general health status decreased
with increasing GOLD stages, an important proportion of
them report their general health as good to excellent.
Together with the disparities observed with dyspnea score
severity and physical activity limitation, these findings most
likely reflect the patient’s underestimation of disease
severity. This emphasizes the need for improved case-
finding measures and multi-component evaluation of diag-
nosed COPD to reduce the burden caused by unrecognized
and underappreciated COPD.Acknowledgments
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